The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians.
The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians.
复制标题
CCR5 delta 32 多态性 (rs333) 与哥伦比亚人的干燥综合征或 1 型糖尿病无关。
DOI:
10.1016/j.clim.2013.05.010
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Scofield,RHal
中科院分区:
文献类型:
--
作者:
Maier-Moore,JacenS;Cañas,CarlosA;Tobón,Gabriel;Arango,Alvaro;Anaya,Juan-Manuel;Scofield,RHal
Sjögren's syndrome (SS) and Type 1 Diabetes (T1D) are chronic, progressive autoimmune diseases that affect exocrine glands or?-cells in the islets of Langerhans in the pancreas, respectively. Typical features of both diseases include production of antibodies against self-antigens and T and B cell infiltrates in organ-specific tissues [12]. Migration of pro-inflammatory memory T cells and monocytes into chronically inflamed tissues is driven by Th1-related chemokines and their receptors. This includes CCR5, a seven-transmembrane domain G protein-coupled receptor (GPCR) involved in intracellular signaling [3]. In Sjögren's syndrome, mRNA and receptor expression of CCR5 are significantly upregulated in inflammatory Th1 cells, parotid gland excretory ducts and conjunctival epithelium of SS-affected individuals indicating that it has a significant role in the progression and severity of pSS disease [45]. In Type 1 Diabetes, recruitment of activated CCR5-expressing T cells to the pancreas or kidney can promote renal disease and impairment of insulin production [6].